gip/glp-1 receptor agonist Main physiological actions of the dual GIP and GLP-1 gip and glp 1 receptor

Extending the findings from the UK cohort study, additional real-world data derived from the Taiwan National Health Insurance Databasewhich encompasses Asian populations characterized by lower gallstone prevalence, low-fat and high-fiber dietary patterns, and lower body mass indexalso documented an elevated risk of biliary-related diseases linked to GLP-1 RAs compared with SGLT-2 inhibitors [36]

These cytokines may cross the bloodbrain barrier, intensifying neurogenic inflammation in the brain

Medline, Embase and Cochrane, to search for studies during pregnancy and/or lactation with maternal exposure to a GLP-1 agonist or an SGLT2 inhibitor ( Supplement 46 )

however, the type, severity, and frequency of these effects may differ between agents, formulations, and dosing schedules

Journal of Molecular and Cellular Cardiology